Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
The Oncologist
|
April 24, 2016
Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment
Sandy R Truong, William T Barry, Javid J Moslehi, et al.
JCO Oncology Practice
|
February 2, 2021
Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic
Robert M Stern, M Dror Michaelson, Erica L Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Breast cancer survivors' perceptions of survivorship care options
Erica L Mayer, Adrienne B Gropper, Bridget A Neville, et al.
Psycho-Oncology
|
September 12, 2021
The effects of a clinic-based weight loss program on health-related quality of life and weight maintenance in cancer survivors: A randomized controlled trial
Justin C Brown, Anita Giobbie-Hurder, Rachel L Yung, et al.
Drugs
|
October 7, 2022
Emerging Targeted Therapies for Early Breast Cancer
Ilana Schlam, Paolo Tarantino, Stefania Morganti, et al.
The Breast Journal
|
July 19, 2019
Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer
Guek Eng Lee, Shoshana M Rosenberg, Erica L Mayer, et al.
Journal of Oncology Practice
|
June 26, 2018
Implementation to Optimization: A Tailored, Data-Driven Approach to Improve Provider Efficiency and Confidence in Use of the Electronic Medical Record
Sarah S Kadish, Erica L Mayer, David M Jackman, et al.
JAMA Surgery
|
April 12, 2023
Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
Olga Kantor, Tari A King, Rachel A Freedman, et al.
Current Oncology Reports
|
May 28, 2025
Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors
Philip D Tracy, Emily Bopp, Emily Milner, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 13, 2011
Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans
Erica L Mayer, Susan M Dallabrida, Maria A Rupnick, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
The Oncologist
|
April 24, 2016
Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment
Sandy R Truong, William T Barry, Javid J Moslehi, et al.
JCO Oncology Practice
|
February 2, 2021
Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic
Robert M Stern, M Dror Michaelson, Erica L Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Breast cancer survivors' perceptions of survivorship care options
Erica L Mayer, Adrienne B Gropper, Bridget A Neville, et al.
Psycho-Oncology
|
September 12, 2021
The effects of a clinic-based weight loss program on health-related quality of life and weight maintenance in cancer survivors: A randomized controlled trial
Justin C Brown, Anita Giobbie-Hurder, Rachel L Yung, et al.
Drugs
|
October 7, 2022
Emerging Targeted Therapies for Early Breast Cancer
Ilana Schlam, Paolo Tarantino, Stefania Morganti, et al.
The Breast Journal
|
July 19, 2019
Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer
Guek Eng Lee, Shoshana M Rosenberg, Erica L Mayer, et al.
Journal of Oncology Practice
|
June 26, 2018
Implementation to Optimization: A Tailored, Data-Driven Approach to Improve Provider Efficiency and Confidence in Use of the Electronic Medical Record
Sarah S Kadish, Erica L Mayer, David M Jackman, et al.
JAMA Surgery
|
April 12, 2023
Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
Olga Kantor, Tari A King, Rachel A Freedman, et al.
Current Oncology Reports
|
May 28, 2025
Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors
Philip D Tracy, Emily Bopp, Emily Milner, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 13, 2011
Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans
Erica L Mayer, Susan M Dallabrida, Maria A Rupnick, et al.
Page
of 12